Anterix Inc.
Financial highlights
| Metric | FY 03/31/26 | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.5M | $6.0M | $4.2M | $1.9M | $1.1M |
| Cost of revenue | — | — | — | $0 | $5,000 |
| Research and development | $4.7M | $5.7M | $5.7M | $4.4M | $3.6M |
| Operating income | $93.9M | -$11.7M | -$10.1M | -$16.5M | -$36.8M |
| Pretax income | $95.7M | -$9.5M | -$7.5M | -$15.1M | -$36.5M |
| Income tax expense | $5.1M | $1.9M | $1.6M | $1.3M | $983,000 |
| Net income | $90.6M | -$11.4M | -$9.1M | -$16.3M | -$37.5M |
| Balance Sheet | |||||
| Cash and equivalents | $98.5M | $47.4M | $60.6M | $43.2M | $105.6M |
| Current assets | $120.0M | $60.8M | $73.0M | $59.5M | $115.8M |
| Total assets | $465.2M | $333.1M | $324.9M | $278.6M | $278.0M |
| Current liabilities | $36.0M | $27.2M | $18.0M | $31.9M | $9.6M |
| Total liabilities | $202.9M | $176.5M | $163.9M | $98.8M | $91.7M |
| Stockholders' equity | $262.3M | $156.6M | $161.0M | $179.8M | $186.3M |
| Cash Flow Statement | |||||
| Cash from operations | $5.5M | -$29.3M | $42.0M | -$27.2M | $17.9M |
| Depreciation and amortization | $464,000 | $548,000 | $844,000 | $1.4M | $1.4M |
| Stock-based compensation | $11.5M | $13.5M | $15.5M | $17.9M | $13.6M |
| Capital expenditure | $31,000 | $87,000 | $307,000 | $2.1M | $1.1M |
| Free cash flow | $5.5M | -$29.4M | $41.7M | -$29.4M | $16.9M |
| Share repurchases | $990,000 | $8.4M | $24.7M | $8.2M | $15.0M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 18.7M · Free float 53.1%
Annual filing data through FY ended March 31, 2026; float as of July 4, 2026.